Host-dependent Induction of Transient Antibiotic Resistance: A Prelude to Treatment Failure

[1]  Margaret A Dudeck,et al.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014 , 2016, Infection Control & Hospital Epidemiology.

[2]  Michael D. Burkart,et al.  Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens , 2015, EBioMedicine.

[3]  D. Andersson,et al.  Amdinocillin (Mecillinam) Resistance Mutations in Clinical Isolates and Laboratory-Selected Mutants of Escherichia coli , 2015, Antimicrobial Agents and Chemotherapy.

[4]  M. Valvano,et al.  Antimicrobial Heteroresistance: an Emerging Field in Need of Clarity , 2015, Clinical Microbiology Reviews.

[5]  Victor I Band,et al.  Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria , 2014, Antibiotics.

[6]  S. Solomon,et al.  Antibiotic resistance threats in the United States: stepping back from the brink. , 2014, American family physician.

[7]  E. Groisman,et al.  The biology of the PmrA/PmrB two-component system: the major regulator of lipopolysaccharide modifications. , 2013, Annual review of microbiology.

[8]  B. Fantin,et al.  Ciprofloxacin Treatment Failure in a Murine Model of Pyelonephritis Due to an AAC(6′)-Ib-cr-Producing Escherichia coli Strain Susceptible to Ciprofloxacin In Vitro , 2013, Antimicrobial Agents and Chemotherapy.

[9]  Gerard D. Wright,et al.  Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions. , 2013, International journal of medical microbiology : IJMM.

[10]  C. Landersdorfer,et al.  Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Paul M. Tulkens,et al.  Pharmacodynamic Evaluation of the Intracellular Activity of Antibiotics towards Pseudomonas aeruginosa PAO1 in a Model of THP-1 Human Monocytes , 2013, Antimicrobial Agents and Chemotherapy.

[12]  Arjun Srinivasan,et al.  Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010 , 2013, Infection Control & Hospital Epidemiology.

[13]  C. Landersdorfer,et al.  Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new? , 2012, Diagnostic microbiology and infectious disease.

[14]  V. Tam,et al.  Pharmacokinetics and Renal Disposition of Polymyxin B in an Animal Model , 2012, Antimicrobial Agents and Chemotherapy.

[15]  Bart C. Weimer,et al.  Intraspecies Variation in the Emergence of Hyperinfectious Bacterial Strains in Nature , 2012, PLoS pathogens.

[16]  K. Kawasaki.  Complexity of lipopolysaccharide modifications in Salmonella enterica: Its effects on endotoxin activity, membrane permeability, and resistance to antimicrobial peptides , 2012 .

[17]  D. Froese,et al.  Antibiotic resistance is ancient , 2011, Nature.

[18]  Jason A. Rosenzweig,et al.  Pathogenesis of Y. enterocolitica and Y. pseudotuberculosis in Human Yersiniosis , 2011, Journal of pathogens.

[19]  M. Falagas,et al.  Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients , 2011, Annals of intensive care.

[20]  N. Salzman,et al.  Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis , 2011, Nature Reviews Microbiology.

[21]  Xavier Monnet,et al.  Hemodynamic parameters to guide fluid therapy , 2011, Annals of intensive care.

[22]  J. Burton,et al.  Rapid Pneumococcal Evolution in Response to Clinical Interventions , 2011, Science.

[23]  Heather K. Allen,et al.  Call of the wild: antibiotic resistance genes in natural environments , 2010, Nature Reviews Microbiology.

[24]  Diarmaid Hughes,et al.  Antibiotic resistance and its cost: is it possible to reverse resistance? , 2010, Nature Reviews Microbiology.

[25]  Thomas Bjarnsholt,et al.  Antibiotic resistance of bacterial biofilms. , 2010, International journal of antimicrobial agents.

[26]  A. Hidrón,et al.  Multidrug Resistance among Gram-Negative Pathogens That Caused Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2006–2008 , 2010, Infection Control & Hospital Epidemiology.

[27]  B. Fantin,et al.  Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. , 2009, The Journal of infectious diseases.

[28]  J. Li,et al.  Pharmacokinetics of intravenous polymyxin B in critically ill patients. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  A. Hidrón,et al.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 , 2008, Infection Control & Hospital Epidemiology.

[30]  John Quale,et al.  Polymyxins Revisited , 2008, Clinical Microbiology Reviews.

[31]  J. Gunn.  The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more. , 2008, Trends in microbiology.

[32]  R. Daynes,et al.  Human Salmonella Clinical Isolates Distinct from Those of Animal Origin , 2008, Applied and Environmental Microbiology.

[33]  O. Steele‐Mortimer.  The Salmonella-containing vacuole: moving with the times. , 2008, Current opinion in microbiology.

[34]  B. Finlay,et al.  Expression and Secretion of Salmonella Pathogenicity Island-2 Virulence Genes in Response to Acidification Exhibit Differential Requirements of a Functional Type III Secretion Apparatus and SsaL* , 2004, Journal of Biological Chemistry.

[35]  O. Berg,et al.  Experimental Adaptation of Salmonella typhimurium to Mice , 2004, Genetics.

[36]  C. Médigue,et al.  Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  P. Tulkens,et al.  Intracellular pharmacodynamics of antibiotics. , 2003, Infectious disease clinics of North America.

[38]  P. Shek,et al.  Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. , 2002, Biochemical pharmacology.

[39]  L. Engstrand,et al.  Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine. , 2001, Nitric oxide : biology and chemistry.

[40]  S. Schwarz,et al.  Molecular characterization, spread and evolution of multidrug resistance in Salmonella enterica typhimurium DT104. , 2001, Veterinary research.

[41]  F. Taddei,et al.  Costs and Benefits of High Mutation Rates: Adaptive Evolution of Bacteria in the Mouse Gut , 2001, Science.

[42]  Masahiko Toyoda,et al.  Pathogenesis of acne , 2001, Medical Electron Microscopy.

[43]  E. Groisman,et al.  A Signal Transduction System that Responds to Extracellular Iron , 2000, Cell.

[44]  F. Baquero,et al.  Mutation Frequencies and Antibiotic Resistance , 2000, Antimicrobial Agents and Chemotherapy.

[45]  D. Low,et al.  An essential role for DNA adenine methylation in bacterial virulence. , 1999, Science.

[46]  D. M. Heithoff,et al.  Differential patterns of acquired virulence genes distinguish Salmonella strains. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[47]  E. Groisman,et al.  Regulation of polymyxin resistance and adaptation to low-Mg2+ environments , 1997, Journal of bacteriology.

[48]  S. Miller,et al.  PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance , 1996, Journal of bacteriology.

[49]  R. Warren,et al.  Molecular characterization of the tia invasion locus from enterotoxigenic Escherichia coli , 1996, Infection and immunity.

[50]  J. Davies,et al.  Origins and Evolution of Antibiotic Resistance , 1996, Microbiology and Molecular Biology Reviews.

[51]  K. Roland,et al.  Isolation and characterization of a gene, pmrD, from Salmonella typhimurium that confers resistance to polymyxin when expressed in multiple copies , 1994, Journal of bacteriology.

[52]  K. Roland,et al.  Spontaneous pmrA mutants of Salmonella typhimurium LT2 define a new two-component regulatory system with a possible role in virulence , 1993, Journal of bacteriology.

[53]  B. Finlay,et al.  Comparison of the invasion strategies used by Salmonella cholerae-suis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication. , 1988, Biochimie.

[54]  J. Burchall.  Mechanism of action of trimethoprim-sulfamethoxazole. II. , 1973, The Journal of infectious diseases.

[55]  G. Hitchings.  Mechanism of action of trimethoprim-sulfamethoxazole. I. , 1973, The Journal of infectious diseases.

[56]  E. P. Kennedy,et al.  Magnesium transport in Escherichia coli. Inhibition by cobaltous ion. , 1971, The Journal of biological chemistry.

[57]  U. Pennsylvania.  Clinical and Laboratory Standards Institute. , 2013 .

[58]  Alison Mack,et al.  Improving food safety through a one health approach: workshop summary. , 2012 .

[59]  H. Juan.  Small Colony Variants: a Pathogenic Form of Bacteria that Facilitates Persistent and Recurrent Infections , 2009 .

[60]  R. Hancock,et al.  Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances , 2008, Nature Protocols.

[61]  Alan Forrest,et al.  Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[62]  M. Lipsitch,et al.  Antibiotic resistance--the interplay between antibiotic use in animals and human beings. , 2003, The Lancet. Infectious diseases.

[63]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[64]  J. Waitz.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[65]  D. Botstein,et al.  Advanced bacterial genetics , 1980 .

[66]  Identification and functional analysis of Salmonella enterica serovar Typhimurium PmrA-regulated genes , 2022 .